Muscle Recovery & Tissue Repair Peptides

BPC-157 (Body Protection Compound) is the most widely studied peptide in the recovery category, with a significant body of preclinical research spanning tendon, muscle, nerve, and gut tissue repair mechanisms. TB-500, derived from thymosin beta-4, has attracted research interest for its role in actin regulation and cellular migration — processes central to healing responses after exercise-induced muscle damage.

Other peptides in this category include thymosin alpha-1, studied in immune modulation contexts that intersect with recovery, and glutathione, a tripeptide antioxidant with a broad research profile in oxidative stress reduction.

BPC-157 is most commonly studied in injectable form — typically subcutaneous administration near the target tissue. The BPC-157 and TB-500 combination is one of the more studied multi-peptide pairings in the recovery category, with complementary mechanisms: BPC-157's angiogenic and growth factor signaling alongside TB-500's actin-regulation and cellular migration effects. Providers offering these compounds are indexed in the PeptideBase directory.

Tissue healing involves overlapping biological processes: inflammation resolution, cellular proliferation, angiogenesis, and extracellular matrix remodelling. BPC-157 and TB-500 have been studied at different points in this cascade — which explains why research often examines them individually and in combination. None of the recovery peptides indexed here have received FDA approval specifically for healing indications; BPC-157 and TB-500 are available through 503A compounding, thymosin alpha-1 has specific international approvals detailed in its profile, and glutathione is available from a broader range of provider types.